نتایج جستجو برای: engerix b
تعداد نتایج: 899347 فیلتر نتایج به سال:
We evaluated the immunogenicity of three recombinant hepatitis B vaccines, one Brazilian (Butang, Instituto Butantan) and two Korean vaccines (Euvax-B, LG Chemical Ltd. and Hepavax-Gene, Greencross Vaccine Corp.), administered intramuscularly to students aged 17 to 19 years in three 10- micro g doses (corresponding to half the amount of antigen routinely used for adult vaccination) at intervals...
conclusions the palestinian and israeli official policies to give a booster dose for risk groups like medical students at anti-hbs level below 10 miu/ml should continue to ensure absolute protection. the currently-used vaccine and its time program cleared virus from students believed to have been exposed to the virus during their lifetime. background hepatitis b infection is a global public hea...
Materials and methods Our database NADIS allows us to collect information from March 1986 to October 2013 (gender, age, CD4 count, HIVRNA and Hepatitis B surface antibody titers = HBs Ab > 10 IU / L.) Patients were included gradually after 3 Engerix B 20 hepatitis B vaccines at day 1, one month and 6 months later, conferring a rate of HBs ab > 10 IU /L. Then we observed the duration of protecti...
To the Editor—It was with interest that we read the study by Frey et al. [1], which describes a randomized trial in which 3 manufacturing consistency lots of a combined hepatitis A and B vaccine were compared with the corresponding monovalent vaccines. The authors observed a nonsatisfactory response to the hepatitis B component in the combined vaccine. We are concerned that this report may be m...
BACKGROUND AND AIMS Currently, vaccination is the most effective protective tool against hepatitis B virus infection. Some studies have shown that positive results for a hepatitis B virus surface antigen (HBsAg) test may be seen after vaccination. MATERIALS AND METHODS In this clinical trial study, 62 healthy adult volunteers were randomly assigned to receive either the Engerix-B or the Hepav...
BACKGROUND Malaria remains a leading global health problem that requires the improved use of existing interventions and the accelerated development of new control methods. We aimed to assess the safety, immunogenicity, and initial efficacy of the malaria vaccine RTS,S/AS02D in infants in Africa. METHODS We did a phase I/IIb double-blind randomised trial of 214 infants in Mozambique. Infants w...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید